Morphometric analysis of pediatric and nonhyperplastic prostate glands: Evidence that BPH is not a unique stromal process

Prostate

Volumn 33, Issue 3, 1997, Pages 177-182

  Shapiro, Ellen ^a,d   Hartanto, Victor ^a,c   Perlman, Elizabeth J ^b   Tang, Rui ^a   Wang, Bo ^a   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

Histology; Prostate; Quantitative morphometry; Smooth muscle

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CADAVER; CELL DENSITY; CHILD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MORPHOMETRICS; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; QUANTITATIVE DIAGNOSIS;

EID: 0030698384     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971101)33:3<177::AID-PROS5>3.0.CO;2-G     Document Type: Article

References (15)

1. Walsh PC: Benign prostatic hyperplasia. In Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds): "Campbell's Urology," 6th ed. Philadelphia: W.B. Saunders, 1992:1007-1022.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
3. McNeal J: Pathology of benign prostatic hyperplasia: Insights into etiology. Urol Clin North Am 1990;17:477.
4. Steiner MS: Review of peptide growth factors in benign prostatic hyperplasia and urologic malignancy. J Urol 1995;153:1085-1093.
5. Shapiro E, Hartanto V, Lepor H: Quantifying the smooth muscle content of the prostate using double immunoenzymatic staining and color assisted image analysis. J Urol 1992;147:1167-1170.
6. Shapiro E, Hartanto V, Lepor H: Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle. Prostate 1992;20:259-267.
7. Shapiro E, Becich MJ, Hartanto V, Lepor H: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 1992;147:1293-1297.
8. Shapiro E, Hartanto V, Lepor H: The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 1992;21:297-307.
9. Andrews GS: The histology of the human fetal and prepubertal prostates. J Anat 1951;85:44-54.
10. Zirkin BR, Strandberg JD: Quantitative changes in the morphology of the aging canine prostate. Anat Rec 1984;208:207-214.
11. Cunha GR: The role of androgens in the epithelio-mesenchymal interactions involved in prostatic morphogenesis in embryonic mice. Anat Rec 1973;175:87-96.
12. Griffin JE, Nilson JD: The testis. In Bondy PK, Rosenberg LE (eds): "Metabolic Control and Disease," Philadelphia: W.B. Saunders, 1980:1535-1579.
13. Lepor H, Shapiro E, Wang Bo, Liang YC: Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men. Urology 1992;47:38-42.
14. Bartsch G, Muller HR, Oberholzer M, Rohr HP: Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979;122:487-491.
15. Lepor H, Wang Bo, Shapiro E: Relationship between prostatic epithelial volume and serum prostate specific antigen levels. Urology 1994;44:199-205.